Candidaturas: 02 de outubro a 15 de dezembro
Início do curso - 15 de janeiro de 2018
Fim - 25 de março
Para mais informações siga o link cursosonline.uminho.pt
The Award “Príncipe da Beira” Biomedical Sciences, established by Dom Manuel II Foundation (Portugal), represented by H.R.H. the Duke of Bragança, in cooperation with the University of Minho and the Municipality of Guimarães, aims primarily to distinguish the excellence in Research and contribute to widening the frontiers of applied research and ethics in Science. [EN]
PERIOD OF APPLICATION: The applications should be submitted between 05th of May and 18th of June 2017.
For more information about The PhD programme on Tissue Engineering, Regenerative Medicine and Stem Cells (TERM&SC) go to http://termsc.3bs.uminho.pt/content/fellowships
For more information about The PhD programme on Advanced Therapies for Health (PATH) go to http://path.3bs.uminho.pt/programme-requirements
The European Research Council (ERC), created by the European Commission and that attributes the most prestigious scientific projects in Europe, is celebrating its 10th Anniversary. In this context, it is organizing from 13th to 17th of March the “ERC Week”, encouraging the institutions beneficiaries of ERC Grants to organize national and/or local events to promote Science and Innovation obtained through ERC funding.
For more information about The PhD programme on Tissue Engineering, Regenerative Medicine and Stem Cells (TERM&SC) go to http://termsc.3bs.uminho.pt/content/fellowships
For more information about The PhD programme on Advanced Therapies for Health (PATH) go to http://path.3bs.uminho.pt/programme-requirements
The call for Grants ICVS/3B’s 2016 is open between March 1st and March 31st, according to the Regulation that you can find in the following link.
Extended Deadline: 2015-10-31
Download PDF or go to online eracareers.pt
Marie Skłodowska Curie Innovative Training Network ‘Tendon Therapy Train’ (H2020-MSCA-ITN- 2015 / #676338) is a research, training and innovation programme that will exploit recent advances in modular engineering to develop novel advanced therapy medicinal products for human and equine tendon repair and regeneration. The network comprises of seven academic institutes, seven companies and two hospitals from six European countries (Ireland, Greece, Netherlands, United Kingdom, Portugal and France).
Deadline: 2015-11-16